A Proof-of-concept Study of TR-012001, a Nasal Levodopa, in Patients with Parkinson’s Disease with OFF Episodes, Without Dopa Decarboxylase Inhibitor (P11-5.009)
TR-012001 is a novel investigational prefilled nasal levodopa product being developed as an on-demand therapy (ODT) to treat OFF episodes in PD.
Authors
- Masahiro Nomoto
- Yuki Akiyoshi
- Yusuke Sumiyoshi
- Chigusa Date
- Satoshi Nakano (ORCID: https://orcid.org/0000-0002-7010-9867)
- Ryosuke Suzuki (ORCID: https://orcid.org/0000-0003-0035-2914)
- Ryota Ise
- Takami Akagi (ORCID: https://orcid.org/0000-0003-0268-1922)
- Hayato Yabe
- Rina Ando
Institutions
- Saiseikai Matsuyama Hospital (JP)
- Saiseikai Ibaraki Hospital (JP)
- Ehime University (JP)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210464
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00